France · 
Who invested in TreeFrog Therapeutics?
TreeFrog Therapeutics's investors include Bpifrance, European Investment Bank and XAnge.
France · Funded startup
Who invested in TreeFrog Therapeutics
Funding summaryUpdated 26 Oct 2026
$34Mraised across 1 round since 2025, from 1 source
- Latest round
- Debt, $34MMay 2025
- Investors
- 3
The rounds
- May 2025
Founders and team
From TreeFrog Therapeutics's own website: 1 founder, 11 on the team.
Maxime FeyeuxCo-Founder
- Mark RotheraChief Executive Officer
- François GianelliChief Regulatory & Quality Officer
- Jens SchröderChief Medical Officer
- Lauriane GillardChief Legal & IP Officer
- Michaël Lanero FidalgoChief Operating Officer
- Myriam MakhloufiChief Strategy Officer
- Peter AndersenChief R&D Officer
- Romain BoiteuxChief People Officer
- Stephanie KrebsHead of Business Development and Alliance Management
- Elsy BoglioliChair, Independent Board Member
- Peter NellIndependent Board Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about TreeFrog Therapeutics
How much has TreeFrog Therapeutics raised?
TreeFrog Therapeutics has raised $34M across 1 round since 2025.
When did TreeFrog Therapeutics last raise?
TreeFrog Therapeutics's most recent round was a Debt of $34M in May 2025.
What was TreeFrog Therapeutics's biggest round?
Its most recent round, $34M in May 2025, is also its largest on record.
Who backed TreeFrog Therapeutics first?
TreeFrog Therapeutics's first round on record, in May 2025, was backed by Bpifrance, European Investment Bank and XAnge.
What stage is TreeFrog Therapeutics at?
TreeFrog Therapeutics's latest named round is a Debt, in May 2025.
Where is TreeFrog Therapeutics based?
TreeFrog Therapeutics is based in France.
Companies like TreeFrog Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.